The most frequently reported clinical adverse events occurring in >5% of patients receiving Kytril were headache, constipation, asthenia, diarrhea, abdominal pain*, dyspepsia*, pain^†, anemia^†, fever^† and elevated hepatic enzymes^†. The use of Kytril in patients following abdominal surgery or in patients with chemotherapy induced nausea and vomiting may mask progressive ileus and/or gastric distention.

*Associated with Kytril Tablets only.
^†Associated with Kytril Injection for postoperative nausea and vomiting only.